← SynDRA
FENRETINIDE
SynDRA canonical compound SYN0000060 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | CYP2C8 | CYP3A5 | RARA | RARG |
| Mechanism of action | apoptosis stimulant | retinoid receptor agonist |
All known targets
Mechanisms of action (all sources)
- apoptosis stimulant
- retinoid receptor agonist
Drug classes
- Anticarcinogenic Agents
- Antineoplastic Agents
Cross-references
Synonyms
- Fenretinida
- 4-hpr
- All-trans-4'-hydroxyretinanilide
- N-(4-hydroxyphenyl)retinamide
- Retinamide, n-(4-hydroxyphenyl)-
- Rii retinamide
- MCN-R-1967
- NSC-760419
- RT-101
- ST-602
- SYT-101
- Fenretinide (pulmonary Pseudomonas aeruginosa infections in cystic fibrosis), McGill University
- LXS/4-HPR
- Fenretinide (Ewing's sarcoma), Cancer Research UK
- Fenretinide (ILE formulation), Children's Hospital LA
- Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles
- Fenretinide (intravenous, cancer), SciTech Development
- Fenretinide (iv), Children's Hospital LA
- Fenretinide (oral, AMD), Sytera
- Fenretinide (soft gel capsule, AMD), ReVision Therapeutics
- Fenretinide (soft gel capsule, AMD), Sirion
- Fenretinide (topical, actinic keratosis and cancer), SciTech Development
- Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx
- Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products
- 4-HPR
- N-(4-Hydroxyphenyl)retinamide
- 4-hydroxyphenylretinamide
- 4-Hydroxyphenyl retinamide
- Retinoic acid p-hydroxyanilide
- all-trans-4'-Hydroxyretinanilide
- McN-R-1967
- Fenretinidum
- 4-hydroxy(phenyl)retinamide
- N-(4-Hydroxyphenyl)all-Trans Retinamide
- Retinamide, N-(4-hydroxyphenyl)-
- Retinoic acid p-hydroxyphenylamide
- 4-(hydroxyphenyl)retinamide
- 15-[(4-hydroxyphenyl)amino]retinal
Look up FENRETINIDE in the interactive SynDRA portal →